Wilson Sonsini Goodrich & Rosati represented Epic Cleantec in the transaction. Epic Cleantec (Epic), a leader in water reuse technology for the built environment, announced the...
Epic Cleantec’s $12 Million Series B Funding Round
Circle Pharma’s $90 Million Series D Financing Round
Wilson Sonsini Goodrich & Rosati represented Circle Pharma in the transaction. Circle Pharma, a clinical-stage biopharmaceutical company, announced the closing of a $90 million Series D...
Regard’s $61 Million Series B Financing Round
Wilson Sonsini Goodrich & Rosati represented Regard in the financing. Regard, an AI-powered clinical insights platform, announced the close of a $61 million Series B financing...
Soleno Therapeutics’ $130 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati advised Soleno Therapeutics on the offering, and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. advised the underwriters. Soleno Therapeutics, Inc....
Soleno Therapeutics’ $120 Million Common Stock Offering and Private Placement
Wilson Sonsini Goodrich & Rosati and Cooley advised Soleno Therapeutics on the deal. Soleno Therapeutics, Inc. (Nasdaq:SLNO), (“Soleno”) announced the pricing of the underwritten public offering of...